IDEXX Laboratories Inc (IDXX)
Pretax margin
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Earnings before tax but after interest (EBT) | US$ in thousands | 1,061,180 | 859,972 | 902,655 | 661,630 | 522,146 |
Revenue | US$ in thousands | 3,660,950 | 3,367,320 | 3,215,360 | 2,706,660 | 2,406,910 |
Pretax margin | 28.99% | 25.54% | 28.07% | 24.44% | 21.69% |
December 31, 2023 calculation
Pretax margin = EBT ÷ Revenue
= $1,061,180K ÷ $3,660,950K
= 28.99%
The pretax margin of Idexx Laboratories, Inc. has shown a generally positive trend over the past five years, increasing from 21.70% in 2019 to 28.99% in 2023. This indicates the company's ability to generate profit before accounting for taxes as a percentage of its total revenue has been improving. The consistent growth in the pretax margin suggests that Idexx Laboratories has been effectively managing its operating expenses and cost structure to enhance profitability. This trend reflects positively on the company's financial health and operational efficiency during the period under review.
Peer comparison
Dec 31, 2023
Company name
Symbol
Pretax margin
IDEXX Laboratories Inc
IDXX
28.99%
Lantheus Holdings Inc
LNTH
32.20%
Myriad Genetics Inc
MYGN
-35.18%
Neogen Corporation
NEOG
-1.36%
Quidel Corporation
QDEL
-0.97%